TrimRx's Blog
Zepbound Eating Disorder: Safety & Risk Considerations
Zepbound isn’t approved for eating disorders and may worsen disordered eating patterns. Understand contraindications, GLP-1 risks, and safer alternatives.
Zepbound Binge Eating — Does It Stop Food Cravings?
Tirzepatide (Zepbound) reduces binge eating episodes by 50–70% in clinical trials through dual GLP-1/GIP receptor activation that normalizes satiety
Zepbound Body Dysmorphia — Weight Loss Reality Check
Zepbound body dysmorphia occurs when weight loss outpaces self-perception. Clinical insights on recognizing distorted body image during GLP-1 therapy.
Zepbound 3 Month Weight Loss — What to Expect | TrimrX
Zepbound delivers 15–20% body weight reduction in three months when combined with structured dietary support and weekly adherence to prescribed doses.
Zepbound 6 Month Weight Loss — Real Results & Timeline
Zepbound users lose 15–21% body weight in six months. This guide covers clinical data, plateau handling, and realistic expectations backed by trial
Zepbound Athletes Performance — Does It Help or Hurt?
Zepbound (tirzepatide) reduces appetite and muscle recovery time — understand the trade-offs before using GLP-1s in athletic contexts.
Zepbound CrossFit — Performance, Safety & Recovery Facts
Zepbound affects CrossFit performance through muscle preservation, recovery timing, and energy availability — here’s what athletes need to know before
Zepbound Powerlifting — Effects, Safety & Performance
Zepbound powerlifting use involves risks: muscle loss, decreased strength output, and compromised recovery. Learn how GLP-1 impacts performance.
Zepbound Marathon Runners — Safe Use and Performance Impact
Zepbound affects endurance, recovery, and race-day energy in marathon runners. Learn safe dosing timelines, GI management strategies, and when to pause
